Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
RecruitingOBSERVATIONAL
Enrollment
150
Participants
Timeline
Start Date
November 1, 2022
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
Conditions
Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionUnaffected Mutation Carriers: Healthy Participants With a Known BMPR2 Gene Mutation and Normal Pulmonary Pressure and RV Function on EchoHealthy Individuals With no Cardiopulmonary Disease